The role of 'statins' in renal transplantation

Martin Lee, Lavjay Butani

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Chronic kidney disease is well recognized to be a state of aberrant lipid metabolism and inflammation, both of which contribute to the cardiovascular morbidity and mortality encountered in this population. Even after successful renal transplantation, both dyslipidemia and the inflammatory milieu persist, and lead not only to premature atherosclerosis, but also to the development of chronic allograft nephropathy and eventual graft loss. The independent adverse effects of, and also the complex interplay between, dyslipidemia and inflammation on vascular health will be discussed in the first part of this chapter. The statins are a group of agents that have potent lipid lowering effects and are being used commonly in the post-transplant period. More recently, the statins have been demonstrated to have immunomodulatory effects independent of their lipid-lowering action. These immunologic effects of the statins may turn out to be of much greater significance for patients with CKD and those with transplants. The latter part of this chapter will address the clinical data demonstrating the beneficial effects of statins in transplant recipients and also discuss the mechanisms by which the statins might mediate these benefits.

Original languageEnglish (US)
Title of host publicationProgress in Kidney Transplantation Research
PublisherNova Science Publishers, Inc.
Pages37-53
Number of pages17
ISBN (Print)9781600213120
StatePublished - 2006

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Kidney Transplantation
Dyslipidemias
Transplants
Inflammation
Lipids
Chronic Renal Insufficiency
Lipid Metabolism
Allografts
Blood Vessels
Atherosclerosis
Morbidity
Mortality
Health
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lee, M., & Butani, L. (2006). The role of 'statins' in renal transplantation. In Progress in Kidney Transplantation Research (pp. 37-53). Nova Science Publishers, Inc..

The role of 'statins' in renal transplantation. / Lee, Martin; Butani, Lavjay.

Progress in Kidney Transplantation Research. Nova Science Publishers, Inc., 2006. p. 37-53.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lee, M & Butani, L 2006, The role of 'statins' in renal transplantation. in Progress in Kidney Transplantation Research. Nova Science Publishers, Inc., pp. 37-53.
Lee M, Butani L. The role of 'statins' in renal transplantation. In Progress in Kidney Transplantation Research. Nova Science Publishers, Inc. 2006. p. 37-53
Lee, Martin ; Butani, Lavjay. / The role of 'statins' in renal transplantation. Progress in Kidney Transplantation Research. Nova Science Publishers, Inc., 2006. pp. 37-53
@inbook{3d79a761d2184dd0aaad0a136e9ad2a5,
title = "The role of 'statins' in renal transplantation",
abstract = "Chronic kidney disease is well recognized to be a state of aberrant lipid metabolism and inflammation, both of which contribute to the cardiovascular morbidity and mortality encountered in this population. Even after successful renal transplantation, both dyslipidemia and the inflammatory milieu persist, and lead not only to premature atherosclerosis, but also to the development of chronic allograft nephropathy and eventual graft loss. The independent adverse effects of, and also the complex interplay between, dyslipidemia and inflammation on vascular health will be discussed in the first part of this chapter. The statins are a group of agents that have potent lipid lowering effects and are being used commonly in the post-transplant period. More recently, the statins have been demonstrated to have immunomodulatory effects independent of their lipid-lowering action. These immunologic effects of the statins may turn out to be of much greater significance for patients with CKD and those with transplants. The latter part of this chapter will address the clinical data demonstrating the beneficial effects of statins in transplant recipients and also discuss the mechanisms by which the statins might mediate these benefits.",
author = "Martin Lee and Lavjay Butani",
year = "2006",
language = "English (US)",
isbn = "9781600213120",
pages = "37--53",
booktitle = "Progress in Kidney Transplantation Research",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - The role of 'statins' in renal transplantation

AU - Lee, Martin

AU - Butani, Lavjay

PY - 2006

Y1 - 2006

N2 - Chronic kidney disease is well recognized to be a state of aberrant lipid metabolism and inflammation, both of which contribute to the cardiovascular morbidity and mortality encountered in this population. Even after successful renal transplantation, both dyslipidemia and the inflammatory milieu persist, and lead not only to premature atherosclerosis, but also to the development of chronic allograft nephropathy and eventual graft loss. The independent adverse effects of, and also the complex interplay between, dyslipidemia and inflammation on vascular health will be discussed in the first part of this chapter. The statins are a group of agents that have potent lipid lowering effects and are being used commonly in the post-transplant period. More recently, the statins have been demonstrated to have immunomodulatory effects independent of their lipid-lowering action. These immunologic effects of the statins may turn out to be of much greater significance for patients with CKD and those with transplants. The latter part of this chapter will address the clinical data demonstrating the beneficial effects of statins in transplant recipients and also discuss the mechanisms by which the statins might mediate these benefits.

AB - Chronic kidney disease is well recognized to be a state of aberrant lipid metabolism and inflammation, both of which contribute to the cardiovascular morbidity and mortality encountered in this population. Even after successful renal transplantation, both dyslipidemia and the inflammatory milieu persist, and lead not only to premature atherosclerosis, but also to the development of chronic allograft nephropathy and eventual graft loss. The independent adverse effects of, and also the complex interplay between, dyslipidemia and inflammation on vascular health will be discussed in the first part of this chapter. The statins are a group of agents that have potent lipid lowering effects and are being used commonly in the post-transplant period. More recently, the statins have been demonstrated to have immunomodulatory effects independent of their lipid-lowering action. These immunologic effects of the statins may turn out to be of much greater significance for patients with CKD and those with transplants. The latter part of this chapter will address the clinical data demonstrating the beneficial effects of statins in transplant recipients and also discuss the mechanisms by which the statins might mediate these benefits.

UR - http://www.scopus.com/inward/record.url?scp=84895286461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895286461&partnerID=8YFLogxK

M3 - Chapter

SN - 9781600213120

SP - 37

EP - 53

BT - Progress in Kidney Transplantation Research

PB - Nova Science Publishers, Inc.

ER -